Michael Floyd - Dec 31, 2021 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Operating Officer
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/6/2022, 04:24 PM
Date Of Original Report
Jan 4, 2022
Previous filing
Apr 4, 2022
Next filing
Apr 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +6.72K +41.86% $0.00 22.8K Dec 31, 2021 Common Stock 6.72K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
F2 This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance.